Literature DB >> 8472416

Surgical treatment of unresolved Osgood-Schlatter lesion.

R Binazzi1, L Felli, V Vaccari, P Borelli.   

Abstract

The Osgood-Schlatter lesion is considered a traction apophysitis. Treatment is generally conservative, and only rarely does a surgical treatment become necessary for the persistence of pain and swelling over the tibial tubercle. The most widely used procedure consists of the excision of all intratendinous ossicles with or without removal of the prominent tibial tubercle. In 15 cases treated in this manner compared with 11 cases treated with various procedures before 1975, the results were clearly better with the former. There was only one fair and no poor results. Removal of all loose intratendinous ossicles associated with prominent tibial tubercles is the procedure of choice, both from the functional and the cosmetic point of view.

Entities:  

Mesh:

Year:  1993        PMID: 8472416

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  5 in total

1.  Osgood-Schlatter Lesion Removed Arthroscopically in an Adult Patient.

Authors:  George Tsakotos; Dimitrios A Flevas; Grigorios G Sasalos; Leonardos Benakis; Anastasios V Tokis
Journal:  Cureus       Date:  2020-03-22

2.  Results of arthroscopic treatment in unresolved Osgood-Schlatter disease in athletes.

Authors:  Esra Circi; Tahsin Beyzadeoglu
Journal:  Int Orthop       Date:  2016-12-21       Impact factor: 3.075

Review 3.  Treatment of Osgood-Schlatter disease: review of the literature.

Authors:  E Circi; Y Atalay; T Beyzadeoglu
Journal:  Musculoskelet Surg       Date:  2017-06-07

Review 4.  Osgood-Schlatter Disease: Appearance, Diagnosis and Treatment: A Narrative Review.

Authors:  Francisco Corbi; Sergi Matas; Jesús Álvarez-Herms; Sebastian Sitko; Ernest Baiget; Joaquim Reverter-Masia; Isaac López-Laval
Journal:  Healthcare (Basel)       Date:  2022-05-30

Review 5.  Apophysitis of the Tibial Tuberosity (Osgood-Schlatter Disease): A Review.

Authors:  Raju Vaishya; Ahmad Tariq Azizi; Amit Kumar Agarwal; Vipul Vijay
Journal:  Cureus       Date:  2016-09-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.